About this Research Topic
Though the field of medicine has experienced extraordinary growth in recent decades, one area in which we keep encountering significant hurdles is targeted cancer therapy. Image-guided nano-radiopharmaceuticals could serve as a new paradigm in cancer therapy, allowing for precise dosage delivery to cancer cells, while using their imaging ability to provide insight on targeting efficiency, off-target effects, and potential toxicity. Recent advances in contemporary imaging and nanoparticle design provide solutions to many of the problems associated with traditional cancer treatment modalities, such as indiscriminate side effects and susceptibility to drug resistance.
The area of image-guided nano-radiopharmaceuticals can harness the accuracy of contemporary imaging techniques and utilize it to direct, dictate, and monitor site-specific drug administration, all of which may be used to further modify cancer therapy on an individual and population basis. As such, the use of image-guided medication administration has increased dramatically in preclinical and clinical trials, although clinical translation is still in its early stages.
This Research Topic focuses on new approaches to targeted drug delivery in cancer, including the use of molecular targeting, as well as the fundamentals of developing nano-based image-guided radiopharmaceuticals, with a particular emphasis on recent preclinical and clinical applications in cancer diagnosis and treatment.
The area of image-guided nano-radiopharmaceuticals can harness the accuracy of contemporary imaging techniques and utilize it to direct, dictate, and monitor site-specific drug administration, all of which may be used to further modify cancer therapy on an individual and population basis. As such, the use of image-guided medication administration has increased dramatically in preclinical and clinical trials, although clinical translation is still in its early stages.
This Research Topic focuses on new approaches to targeted drug delivery in cancer, including the use of molecular targeting, as well as the fundamentals of developing nano-based image-guided radiopharmaceuticals, with a particular emphasis on recent preclinical and clinical applications in cancer diagnosis and treatment.
Keywords: Radiopharmaceuticals, Nanotechnology, Theranostic Applications, Molecular targeting
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
